Current Value
$1.071 Year Return
Current Value
$1.071 Year Return
Yahoo
On Friday, Mersana Therapeutics Inc. (NASDAQ:MRSN) released initial data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin. Emi-Le was generally well tolerated, with no Grade 4 or 5 treatment-related adverse events reported. At intermediate doses in the trial (38.1 mg/m2 to 67.4 mg/m2), the confirmed objective response rate among evaluable patients was 23% (6 of 26 patients) across all B7-H4 high tumors and 23% (3 of 13 patients) with B7-H4 high TNBC, all of whom had
Yahoo
Conference call to discuss positive initial Phase 1 clinical data today at 8:30 a.m. ETCAMBRIDGE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the U.S. Food and Drug Administration (FDA) recently granted an additional Fast Track designation to XMT-1660. The compa
Yahoo
- Emiltatug ledadotin observed to be generally well tolerated with differentiated safety and tolerability profile- Promising clinical activity observed in patients with triple-negative breast cancer (TNBC) previously treated with topoisomerase-1 inhibitor (topo-1) ADCs; confirmed responses observed across all enrolled tumor types- First expansion cohort initiated in patients with TNBC previously treated with at least one topo-1 ADC; dose exploration efforts ongoing- Company announces expected 20
Finnhub
Initial Phase 1 Dose Escalation Data for Emi-Le January 10, 2025 ...
Finnhub
By Colin Kellaher Mersana Therapeutics shares rose sharply after the biopharmaceutical company won a second Food and Drug Administration fast-track designation for a proposed treatment for breast...
SeekingAlpha
Mersana Therapeutics is utilizing antibody-drug conjugates to target new immune checkpoints and revolutionize cancer treatment. See why MRSN looks interesting now.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
WEC | -0.01% | $29.97B | +10.70% | 3.57% |
NVS | 0.03% | $196.08B | -6.72% | 3.77% |
EXEL | -0.06% | $9.85B | +50.92% | 0.00% |
WTW | 0.09% | $31.64B | +27.99% | 1.13% |
TH | 0.10% | $961.71M | +4.97% | 0.00% |
D | -0.14% | $45.86B | +13.92% | 4.98% |
BSM | 0.14% | $3.08B | -10.03% | 10.76% |
HIHO | -0.17% | $8.50M | -4.46% | 6.22% |
FRO | -0.17% | $3.52B | -27.42% | 11.35% |
CANG | -0.19% | $344.76M | +366.67% | 0.00% |
UNH | -0.19% | $482.71B | -2.44% | 1.54% |
T | -0.20% | $159.15B | +31.48% | 5.12% |
SSL | -0.20% | $2.78B | -51.75% | 2.14% |
FF | -0.24% | $226.26M | +28.39% | 4.70% |
DG | 0.28% | $15.75B | -46.58% | 4.13% |
BG | 0.29% | $10.80B | -18.47% | 3.45% |
FAT | 0.29% | $91.08M | -15.20% | 10.51% |
LAKE | 0.31% | $186.25M | +44.46% | 0.48% |
APD | 0.32% | $63.44B | +6.85% | 2.42% |
CCSI | -0.32% | $458.07M | +19.61% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRNX | 46.89% | $4.50B | +28.99% | 0.00% |
DYN | 44.28% | $2.35B | +32.93% | 0.00% |
ACEL | 41.75% | $865.43M | +4.47% | 0.00% |
IGMS | 41.71% | $368.68M | -43.97% | 0.00% |
NEO | 41.24% | $2.39B | +16.53% | 0.00% |
RGNX | 40.05% | $410.73M | -44.25% | 0.00% |
NTLA | 39.79% | $1.22B | -58.38% | 0.00% |
ALLO | 39.45% | $492.73M | -25.87% | 0.00% |
SXT | 39.20% | $2.99B | +11.87% | 2.43% |
PSMT | 38.66% | $2.87B | +23.68% | 1.29% |
ACA | 38.10% | $4.63B | +20.52% | 0.22% |
ALNT | 37.37% | $429.22M | -10.12% | 0.51% |
BN | 37.21% | $88.06B | +46.94% | 0.58% |
MTRX | 37.19% | $345.54M | +31.17% | 0.00% |
BNT | 36.54% | $7.50B | +46.52% | 0.00% |
FATE | 36.51% | $190.20M | -63.46% | 0.00% |
BAM | 36.23% | $23.38B | +41.79% | 2.88% |
DLX | 36.17% | $973.55M | +8.59% | 5.60% |
ATXS | 36.10% | $471.23M | +11.93% | 0.00% |
DNLI | 35.79% | $3.06B | +13.09% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RPRX | -19.09% | $11.64B | -8.96% | 2.94% |
CME | -17.16% | $82.63B | +15.91% | 4.55% |
CBOE | -14.65% | $20.20B | +9.90% | 1.22% |
AGS | -13.86% | $477.21M | +50.06% | 0.00% |
MNOV | -13.29% | $97.60M | +33.11% | 0.00% |
WBA | -11.28% | $7.96B | -62.64% | 8.85% |
OCX | -9.29% | $37.54M | -34.02% | 0.00% |
FATBB | -9.05% | $80.25M | -14.94% | 11.99% |
HUSA | -7.91% | $20.15M | -6.10% | 0.00% |
LTM | -6.78% | $8.18B | -100.00% | <0.01% |
USM | -6.70% | $5.25B | +48.18% | 0.00% |
VITL | -6.30% | $1.72B | +153.74% | 0.00% |
VHC | -5.84% | $26.48M | +14.70% | 0.00% |
NOC | -5.81% | $67.34B | -2.06% | 1.76% |
CI | -5.80% | $77.69B | -9.23% | 2.00% |
STG | -5.75% | $28.35M | -39.33% | 0.00% |
TXO | -5.29% | $686.93M | -11.63% | 14.06% |
TNK | -5.17% | $1.44B | -19.34% | 2.21% |
PRPH | -5.01% | $14.06M | -88.31% | 0.00% |
BAH | -4.98% | $16.62B | +2.25% | 1.53% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CANE | -0.11% | $12.08M | 0.29% |
MINT | -0.30% | $11.98B | 0.35% |
GOVZ | 0.31% | $269.61M | 0.1% |
GBIL | 0.52% | $5.84B | 0.12% |
CLOI | 0.62% | $792.56M | 0.4% |
CMDY | -0.72% | $282.97M | 0.28% |
IBTF | -0.76% | $2.23B | 0.07% |
BILS | 0.81% | $3.33B | 0.1356% |
SEIX | 0.82% | $300.05M | 0.62% |
ZROZ | 0.83% | $1.50B | 0.15% |
MSOS | 0.85% | $505.06M | 0.83% |
PDBC | -0.87% | $4.17B | 0.59% |
BCD | 0.88% | $233.79M | 0.3% |
ULST | 0.96% | $539.53M | 0.2% |
BCI | -1.40% | $1.31B | 0.26% |
FTGC | -1.40% | $2.24B | 1.02% |
DBC | -1.48% | $1.31B | 0.87% |
CSHI | -1.65% | $508.09M | 0.38% |
ICLO | 1.67% | $287.21M | 0.2% |
KRBN | -1.69% | $199.62M | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -24.89% | $195.31M | 0.85% |
TAIL | -16.78% | $65.56M | 0.59% |
CTA | -14.37% | $483.80M | 0.76% |
USDU | -8.40% | $379.83M | 0.5% |
XBIL | -8.31% | $641.82M | 0.15% |
WEAT | -7.89% | $119.67M | 0.28% |
BIL | -7.86% | $36.56B | 0.1356% |
SGOV | -7.53% | $30.65B | 0.09% |
CORN | -7.35% | $63.58M | 0.2% |
UNG | -7.22% | $746.57M | 1.06% |
TBIL | -6.49% | $4.78B | 0.15% |
FLRN | -5.74% | $2.46B | 0.15% |
XHLF | -5.60% | $939.75M | 0.03% |
IBMN | -5.09% | $488.10M | 0.18% |
DBE | -5.06% | $48.32M | 0.77% |
DBO | -4.53% | $216.94M | 0.77% |
COMT | -4.51% | $694.40M | 0.48% |
GSG | -4.16% | $1.02B | 0.75% |
CCOR | -3.73% | $83.85M | 1.18% |
SOYB | -3.46% | $24.83M | 0.22% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPA | 48.86% | $270.13M | 0% |
XBI | 45.08% | $6.39B | 0.35% |
GNOM | 44.64% | $71.12M | 0.5% |
IWC | 43.99% | $965.33M | 0.6% |
IWO | 43.79% | $12.83B | 0.24% |
VTWO | 42.63% | $12.40B | 0.1% |
IWM | 42.48% | $72.22B | 0.19% |
QQA | 42.18% | $144.94M | 0% |
PTH | 42.11% | $122.57M | 0.6% |
RYLD | 42.02% | $1.47B | 0.6% |
PBE | 41.93% | $251.02M | 0.58% |
GSSC | 41.84% | $529.38M | 0.2% |
ISCG | 41.45% | $641.73M | 0.06% |
VBK | 41.27% | $19.73B | 0.07% |
IBB | 41.22% | $6.59B | 0.45% |
SMMD | 41.12% | $1.37B | 0.15% |
ESML | 40.89% | $1.89B | 0.17% |
NUSC | 40.79% | $1.24B | 0.31% |
TMSL | 40.62% | $401.12M | 0.55% |
VXF | 40.61% | $21.57B | 0.06% |